Lipid-lowering drugs and erectile dysfunction [2]

Family Practice

Volumn 19, Issue 5, 2002, Pages 567-

  Blanker, Marco H ^a   Verhagen, Arianne P ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; CLOFIBRATE; FIBRIC ACID DERIVATIVE;

ACCURACY; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; INFORMATION PROCESSING; LETTER; MEDICAL INFORMATION;

EID: 0036772518     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/19.5.567     Document Type: Letter

References (4)

1. Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract 2002;19: 95-98.
2. Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994;140:930-937.
3. Vogt HJ. [Letter: Impotence caused by clofibrate therapy] Impotenz durch Behandlung mit Clofibrat [German]. Med Klin 1976; 71: 257.
4. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine: How to Practice and Teach EBM, 2nd edn. Edinburgh: Churchill Livingstone, 2000.